IL-1 alpha, human recombinant protein
Hematopoietin-1, Lymphocyte-activating factor (LAF), Endogenous Pyrogen (EP), Leukocyte Endogenous M
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P01583 |
---|---|
Calculated MW | 18.0 kDa |
Gene ID | 3552 |
---|---|
Gene Symbol | IL1A |
Other Names | Hematopoietin-1, Lymphocyte-activating factor (LAF), Endogenous Pyrogen (EP), Leukocyte Endogenous Mediator (LEM), Mononuclear Cell Factor (MCF) |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥98% |
Assay2&Purity2 | HPLC; ≥98% |
Recombinant | Yes |
Results | <0.001 ng/ml |
Target/Specificity | IL-1 alpha |
Application Notes | Reconstitute in H₂O to a concentration of 0.1-1 mg/ml. The solution can then be diluted into other aqueous buffers and stored at 4°C for 1 week or –20°C for future use. |
Format | Lyophilized protein |
Storage | -20°C; Sterile filtered and lyophilized powder |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
IL-1α is a potent immuno-modulator that mediates a wide range of immune and inflammatory responses. BioVision’s Human IL-1α is an 18.0 kDa protein containing 159 amino acid residues.
References
March C.J.,et al.Nature 315:641-647(1985).
Furutani Y.,et al.Nucleic Acids Res. 14:3167-3179(1986).
Furutani Y.,et al.Nucleic Acids Res. 13:5869-5882(1985).
Kotenko S.V.,et al.Dokl. Akad. Nauk SSSR 309:1005-1008(1989).
Gubler U.,et al.J. Immunol. 136:2492-2497(1986).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.